sedApta & Vineti together for cell and gene therapies

The partnership to develop integrated digital supply chain and manufacturing solution for cell and gene therapies!

Giessen, Germany and San Francisco, CA, April 20th 2022A new partnership between sedApta Group and  Vineti is born. The non-exclusive partnership will create an integrated digital solution between leaders in smart manufacturing, digital supply chain management, Chain of Identity (COI) and Chain of Custody (COC), and cell and gene therapy workflows.

“As the only company of our kind supporting both clinical-phase and commercial advanced therapies, we know what it takes to support these therapeutics at all phases of development. By partnering with sedApta, we’ll develop an integrated solution that truly optimizes the cell and gene therapy process.” says Ann Klein, CEO of Vinetiread more